In line with our finding, that nearly every T-PLL case presents with a genomic aberration that potentially causes activated JAK/STAT signaling, we could not observe any differential association of the JAK/STAT mutation status with clinical characteristics, i.e., those indicating a more aggressive phenotype of T-PLL cells. This evidence concerns the gene SOAT1 and prolymphocytic leukemia.